The board has recommended a final dividend payout of Rs 1.50 per share. In FY23, Biocon’s revenue grew almost 37% to Rs 11,174 crore, while its net profit fell nearly 29% to Rs 463 crore. The biosimilars business segment more than doubled its year-on-year revenue to INR2,102 crore in Q4 2022.
HDFC Bank shares in focus post Q3 earnings. Should you buy, sell, or hold?
HDFC Bank’s shares are in focus after the lender posted a 2.2% YoY growth in net profit for Q3FY25, reaching Rs 16,736 crore, which fell
January 23, 2025